Pain Management & Opioid Therapy Guidelines from the Veterans Administration & Department of Defense | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Lewis Agnor
B01=Mark O'Connor
Category1=Non-Fiction
Category=JWXV
Category=MMBP
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=In stock
Price_€100 and above
PS=Active
softlaunch

Pain Management & Opioid Therapy Guidelines from the Veterans Administration & Department of Defense

English

The VA/DoD published the first Clinical Practice Guideline for management of opioid therapy for chronic pain in 2003. This original publication was intended to improve pain management, quality of life, and quality of care for veterans. The focus of the guideline has been to provide education and guidance to primary care clinicians, researchers and other health professionals as they encounter patients with persistent pain and its complications. This book aims to update the evidence base of the 2003 Guideline. It is focused, as was the original CPG, on chronic opioid therapy (opioid therapy for more than one month). It is directed to the clinician who is interested in knowing more about this approach to the management of chronic pain. See more
Current price €306.89
Original price €340.99
Save 10%
Age Group_Uncategorizedautomatic-updateB01=Lewis AgnorB01=Mark O'ConnorCategory1=Non-FictionCategory=JWXVCategory=MMBPCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=In stockPrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 788g
  • Dimensions: 180 x 260mm
  • Publication Date: 08 Apr 2013
  • Publisher: Nova Science Publishers Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781624177712
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept